Una de las señales de que España es uno de los países de referencia respecto las aplicaciones de células madre es tener médicos y científicos de la envergadura de José María Moraleda Jimenez o Damián García Olmo. Otro muy importante es que además se unen para crear cursos de alto nivel académico sobre las aplicaciones de las células madre como el UNIMAR-CMN. El curso se ha realizado esta semana, desde el lunes 14 al viernes 19, y en él se han participado tanto especialistas de España como de otros países de Europa y EEUU para tocar todos los puntos importantes sobre las particularidades de estas células y sus terapias.
La dirección ha estado a cargo de 4 doctores, D. José María Moraleda Jimenez, Salvador Martínez Pérez, D. Damián García Olmo, y D. Robert Sackstein. No menos importante es la labor de coordinación realizada por Francisca Iniesta Martinez y Javier Sanchez Garcia.
Para que veas la cantidad de personalidades que estuvieron reunidas en las 25 horas que ha durado el curso sólo necesitas echarle un vistazo al programa del curso.
Lunes 15 Bone Marrow Stem Cells: Hematopoietic Stem Cells (HSC) and Hematopoietic Stem Cell Transplantation (HSCT)
09:30 h. Ponencia: The Biology of the Hematopoietic Stem Cell
Dra. Dña. Carmen Luisa Garcia de Insausti
Asociado Ciencias de la Salud. Murcia.
10:00 h. Ponencias: Obtaining Hematopoietic Progenitors: Cellular Selection
Dr. D. Miguel Blanquer Blanquer
Hematólogo HCUVA. Murcia.
10:30 h. Pausa. Coffee break
11:00 h. Ponencia: HSCT: Technique and Complications
Prof. Dr. D. José María Moraleda Jiménez
Professor of Medicine. University of Murcia. Chief, Department of Haematology and HSCT Program. Virgen de la Arrixaca University Hospital. Murcia, Spain.
11:30 h. Ponencia: Umbilical Cord Blood Transplantation
Prof. Dr. D. Robert Danby
Scientific. Director of Eurocard Registry.Departmen of Hematology BMT. Hospital Saint Louis, University of Paris. France..
12:15 h. Ponencia: Principles and Practice of Non-myeloablative HSCT
Prof. Dr. D. Sergio A. Giralt
Professor of Medicine Weill Cornell College of Medicine. Chief Adult Bone Marrow Transplant Service. Division of Hematologic Oncology. Memorial Sloan-Kettering Cancer Center. New York, USA.
13:00 h. Pausa. Lunch
15:00 h. Ponencia: Short Lecture: Curing Hemoglobinopathies
Prof. Dr. D. Franco Locatelli
President of the Italian association for Pediatric Hematology and Oncology. Research Center, Bambino Gesù Children Hospital, Roma, Italy.
15:30 h. DEBATE: DEBATE SESSION: HISTOCOMPATIBILITY ANTIGEN (HLA) TYPING, HSC DONATION, AND REGISTRY ISSUES.
The Spanish Model
Gregorio Garrido Cantarero. Head of Service, Spanish National Transplant Organization (ONT). Madrid, Spain.
The French Registry
Prof. Dr. D. Robert Danby. Scientific. Director of Eurocard Registry.Departmen of Hematology BMT. Hospital Saint Louis, University of Paris. France..
The Great Britain Experience
Prof. Dr. D. José Alejandro Madrigal Fernández. European Bone Marrow Transplant Association President. London, U.K. Scientific Director of The Anthony Nolan Trust. Chair of Haematology, Department of Haematology. The Royal Free and University College Medical School. London, UK.
Prof. Dr. D. José María Moraleda Jiménez
Professor of Medicine. University of Murcia. Chief, Department of Haematology and HSCT Program. Virgen de la Arrixaca University Hospital. Murcia, Spain.
Martes 16 New HSCT Approches: HSCT Immunotherapy
09:00 h. Ponencia: The Immunotherapeutic Role of HSCT
Prof. Dr. D. Andrea Bacigalupo
Head Department of Hematology and Stem Cell Transplant Unit. Ospedale San Martino. Genova. Italy.
09:45 h. Ponencia: Haploidentical Transplants and Role of NK Immunotherapy
Prof. Dr. D. Franco Locatelli
President of the Italian association for Pediatric Hematology and Oncology. Research Center, Bambino Gesù Children Hospital, Roma, Italy.
10:30 h. Pausa. Coffee break
11:00 h. Ponencia: New Strategies for Post-transplant Immunomodulation
Prof. Dr. D. José Alejandro Madrigal Fernández
European Bone Marrow Transplant Association President. London, U.K. Scientific Director of The Anthony Nolan Trust. Chair of Haematology, Department of Haematology. The Royal Free and University College Medical School. London, UK.
11:45 h. Ponencia: Unrelated Donor Transplants. The MSK Experience in HSCT Immunomodulation
Prof. Dr. D. Sergio A. Giralt
Professor of Medicine Weill Cornell College of Medicine. Chief Adult Bone Marrow Transplant Service. Division of Hematologic Oncology. Memorial Sloan-Kettering Cancer Center. New York, USA.
12:30 h. Pausa. Lunch
14:30 h. DEBATE: Debate session: Harnessing GVL Effect while Avoiding GVHD. What is the best URD transplant?
URD unmanipulated SCT
Prof. Dr. D. Robert Sackstein. Professor, and Director of the Program of Excellence in Glycoscience, Harvard Medical School, Boston, MA, USA.
Discussants:
Prof. Dr. D. Robert Sackstein. Professor, and Director of the Program of Excellence in Glycoscience, Harvard Medical School, Boston, MA, USA.
Prof. Dr. D. José Alejandro Madrigal Fernández. European Bone Marrow Transplant Association President. London, U.K. Scientific Director of The Anthony Nolan Trust. Chair of Haematology, Department of Haematology. The Royal Free and University College Medical School. London, UK.
Prof. Dr. D. Franco Locatelli. President of the Italian association for Pediatric Hematology and Oncology. Research Center, Bambino Gesù Children Hospital, Roma, Italy.
Prof. Dr. D. Sergio A. Giralt. Professor of Medicine Weill Cornell College of Medicine. Chief Adult Bone Marrow Transplant Service. Division of Hematologic Oncology. Memorial Sloan-Kettering Cancer Center. New York, USA.
Prof. Dr. D. Robert Danby. Scientific. Director of Eurocard Registry.Departmen of Hematology BMT. Hospital Saint Louis, University of Paris. France..
Prof. Dr. D. Andrea Bacigalupo. Head Department of Hematology and Stem Cell Transplant Unit. Ospedale San Martino. Genova. Italy.
Miércoles 17 MORNING: Bone Marrow Stem Cells: Mesenchymal Stem Cells (MSC) and Mesenchymal Stem Cell Transplantation. AFTERNOON: Induced Pluripotent Stem Cells (iPSC)
09:00 h. Ponencia: The stem Cell Niche
Prof. Dr. D. Agustín Gregorio Zapata González
Professor of Cellular Biology. Complutense University of Madrid. Spain.
09:30 h. Ponencia: The Regulation of the Stem Cell Microenvironment
Dr. D. Simón Méndez Ferrer
National Center for Cardiovascular Research (CNIC). Madrid, Spain.
10:00 h. Ponencia: MSC: A New Paradigm for Cell Immunomodulation
Prof. Dr. D. Antonio Uccelli
Professor of Neurology. Neuroimmunology Unit. Dept of Neurosicences, University of Genova. Italy.
10:45 h. Pausa. Coffee break
11:15 h. Ponencia: Stem Cell Trafficking: Biology and Manipulation via GPS
Prof. Dr. D. Robert Sackstein
Professor, and Director of the Program of Excellence in Glycoscience, Harvard Medical School, Boston, MA, USA.
Prof. Dr. D. José María Moraleda Jiménez
Professor of Medicine. University of Murcia. Chief, Department of Haematology and HSCT Program. Virgen de la Arrixaca University Hospital. Murcia, Spain.
Dra. Dña. Mª Dolores López Lucas
Unidad de Trasplante y Terapia Celular. Hospital Clínico Universitario Virgen de la Arrixaca. University of Murcia. Spain.
12:30 h. Ponencia: The production os MSC for clinical use: GMP cell facilities
Prof. Dra. Dña. Ana Sánchez García
Professor of Physiology. School of Medicine. Institute of Biology and Molecular Genetics (IBGM). University of Valladolid, Spain.
13:00 h. Pausa. Lunch
15:00 h. Ponencia: iPSC as a Therapeutic Tool
Prof. Dr. D. Ángel Raya Chamorro
ICREA Research Professor. Institute for Bioengineering of Catalonia. Barcelona, Spain.
15:30 h. Ponencia: iPSC and Gene Therapy for Genetic Diseases
Prof. Dr. D. Juan Antonio Bueren Roncero
Head of the Division of Hematopoiesis and Gene Therapy Division CIEMAT. University of Madrid. Spain.
Jueves 18 Stem Cell Therapy (SCT). Clinical Trials in Non-neurologic Diseases
09:00 h. Ponencia: SCT in Cardiac Diseases
Prof. Dr. D. Felipe Prosper Cardoso
Director of Cell Therapy Department. Co-director Hematology Dpt. University of Navarra. Navarra, Spain.
09:30 h. Ponencia: SCT in Diabetes Mellitus and its Complications
Prof. Dr. D. Bernat Soria Escoms
Director of the Stem Cells Department of the Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER). University Pablo de Olavide. Seville, Spain.
10:00 h. Ponencia: SCT to Improve Surgical Healing
Prof. Dr. D. Damián García Olmo
Professor of Surgery. Director of Cell Therapy Unit and Head of Colorectal Surgery Unit. La Paz University Hospital. Autonomous University of Madrid. Spain.
10:30 h. Pausa. Coffee break
11:00 h. Ponencia: SCT for Bone Repair
Prof. Dr. D. Francisco Javier García-Sancho Martín
Professor of Physiology. School of Medicine. Institute of Biology and Molecular Genetics (IBGM). University of Valladolid. Spain.
11:30 h. Ponencia: SCT for Cartilage Repair
Prof. Dr. D. Pedro Guillén García
Clinical Research Unit, CEMTRO Hospital. Madrid, Spain.
12:00 h. Ponencia: SCT for Treatment of Transplant Rejection and GVHD
Dr. D. Fermín M. Sánchez Guijo
Hematology Department. University Hospital of Salamanca. University of Salamanca. Spain.
13:00 h. Pausa. Lunch
15:00 h. Ponencia: SCT in Ophthalmology
Prof. Dra. Dña. Margarita Calonge
Professor of Ophthalmology. Director, Ocular Immunology Unit, IOBA, University of Valladolid. Spain.
15:30 h. Ponencia: SCT in Odontology
Prof. Dr. D. Francisco Javier Rodríguez Lozano
Professor of Dentistry. Cell Therapy Research Group. Virgen de la Arrixaca Clinical University Hospital. University of Murcia. IMIB.Spain.
Viernes 19 Stem Cell Therapy (SCT). Clinical Trials in Neurologic Diseases
09:00 h. Ponencia: The Neural Stem Cell niche
Prof. Dra. Dña. Isabel Fariñas Gómez
Professor of Cellular Biology. Dept. of Cellular Biology. University of Valencia CIPF. Valencia, Spain.
09:30 h. Ponencia: SCT in Parkinson's Disease
Prof. Dr. D. Juan José Toledo Aral
Professor of Physiology. Department of Medical Physiology and Biophysics. University of Seville. Seville, Spain.
10:00 h. Ponencia: SCT in ALS
Dra. Dña. Letizia Mazzini
Head of the tertiary ALS Center. Department of Neurology, Eastern Piedmont. University, Maggiore della Carità Hospital. Novara, Italy.
10:30 h. Pausa. Coffee break
11:00 h. Ponencia: SCT in Neurodegenerative Diseases (ND). Results in Animal Models
Prof. Dr. D. Salvador Martínez Pérez
Professor of Neuro-Anatomy and Embryology. Experimental Embryology Lab. Institute of Neurosciences-CSIC, Universidad Miguel Hernández. Alicante, Spain.
11:30 h. Ponencia: SCT for other ND-Neuromuscular diseases
Prof. Dr. D. Antonio Uccelli
Professor of Neurology. Neuroimmunology Unit. Dept of Neurosicences, University of Genova. Italy.
12:00 h. Ponencia: Stem cell differentiation for cell replacement strategies in ND
Prof. Dr. D. Josep M. Canals Coll
Professor of Cellular Biology. Dept. of Cell Biology, Immunology and Neuroscience. University of Barcelona. Barcelona, Spain.
13:00 h. Pausa. Lunch
15:00 h. DEBATE: Debate session: Stem Cell Therapy pros and cons. How do we move ahead?
Lecture 1
Prof. Dr. D. Salvador Martínez Pérez. Professor of Neuro-Anatomy and Embryology. Experimental Embryology Lab. Institute of Neurosciences-CSIC, Universidad Miguel Hernández. Alicante, Spain.
Lecture 2
Prof. Dr. D. Antonio Uccelli. Professor of Neurology. Neuroimmunology Unit. Dept of Neurosicences, University of Genova. Italy.
Lecture 3
Prof. Dr. D. Felipe Prosper Cardoso. Director of Cell Therapy Department. Co-director Hematology Dpt. University of Navarra. Navarra, Spain.
Lecture 4
Dra. Dña. Letizia Mazzini. Head of the tertiary ALS Center. Department of Neurology, Eastern Piedmont. University, Maggiore della Carità Hospital. Novara, Italy.
Lecture 5
Prof. Dr. D. Robert Sackstein. Professor, and Director of the Program of Excellence in Glycoscience, Harvard Medical School, Boston, MA, USA.
Prof. Dr. D. Agustín Gregorio Zapata González
Professor of Cellular Biology. Complutense University of Madrid. Spain.
